Taken together, our data reveal novel cellular and molecular phenotypes in human cells with clinically relevant TCF4 mutations and show that these aberrations are reversible, providing routes for therapeutic intervention in individuals carrying genetic diseases associated with this gene. Here, TCF4 is linked to hereditary disease.